Fin Trust Capital Advisors, LLC Novartis Ag Transaction History

Fin Trust Capital Advisors, LLC

  • $577 Million
  • Q3 2024

A detailed history of Fin Trust Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 1,435 shares of NVS stock, worth $157,075. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,435
Previous 1,446 0.76%
Holding current value
$157,075
Previous $153,000 7.84%
% of portfolio
0.03%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
SELL
$106.13 - $120.89 $1,167 - $1,329
-11 Reduced 0.76%
1,435 $165,000
Q2 2024

Jul 24, 2024
BUY
$92.57 - $107.37 $6,665 - $7,730
72 Added 5.24%
1,446 $153,000
Q1 2024

May 02, 2024
SELL
$95.27 - $108.47 $31,439 - $35,795
-330 Reduced 19.37%
1,374 $132,000
Q3 2023

Oct 24, 2023
BUY
$94.73 - $105.13 $55,322 - $61,395
584 Added 52.14%
1,704 $173,000
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $37,775 - $46,260
500 Added 80.65%
1,120 $101,000
Q3 2022

Oct 20, 2022
SELL
$74.61 - $87.26 $447 - $523
-6 Reduced 0.96%
620 $48,000
Q2 2022

Jul 26, 2022
BUY
$80.52 - $93.75 $322 - $375
4 Added 0.64%
626 $54,000
Q1 2022

May 03, 2022
SELL
$80.11 - $90.62 $15,541 - $17,580
-194 Reduced 23.77%
622 $54,000
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $55,790 - $61,691
-700 Reduced 46.17%
816 $71,000
Q3 2021

Nov 16, 2021
BUY
$81.78 - $95.14 $17,664 - $20,550
216 Added 16.62%
1,516 $124,000
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $21,736 - $24,008
255 Added 24.4%
1,300 $119,000
Q1 2021

May 17, 2021
SELL
$83.5 - $98.47 $46,843 - $55,241
-561 Reduced 34.93%
1,045 $89,000
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $2,029 - $2,455
26 Added 1.65%
1,606 $152,000
Q3 2020

Nov 10, 2020
BUY
$82.14 - $91.0 $38,605 - $42,770
470 Added 42.34%
1,580 $137,000
Q2 2020

Sep 11, 2020
BUY
$80.93 - $91.1 $89,832 - $101,121
1,110 New
1,110 $97,000
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $74,293 - $83,629
-918 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $33,921 - $47,524
480 Added 109.59%
918 $76,000
Q4 2019

Jan 23, 2020
BUY
$84.35 - $95.37 $1,771 - $2,002
21 Added 5.04%
438 $41,000
Q3 2019

Oct 29, 2019
SELL
$85.54 - $94.26 $1,112 - $1,225
-13 Reduced 3.02%
417 $36,000
Q2 2019

Aug 01, 2019
SELL
$75.4 - $92.8 $29,255 - $36,006
-388 Reduced 47.43%
430 $40,000
Q1 2019

May 09, 2019
SELL
$75.32 - $86.15 $60,557 - $69,264
-804 Reduced 49.57%
818 $78,000
Q4 2018

Feb 11, 2019
BUY
$73.66 - $82.02 $119,476 - $133,036
1,622 New
1,622 $139,000

Others Institutions Holding NVS

# of Institutions
1,487
Shares Held
131M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $235B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email